Abstract
Although kidney transplantation (KTx) prolongs life and improves quality of life, it remains a chronic illness, in which patients require continued medical follow-up to monitor graft function and lifelong medication intake. Adherence (also called compliance or concordance) can be defined as the extent to which a person’s behavior (taking medications, following a recommended diet, and/or executing lifestyle changes) corresponds with the agreed recommendations of a healthcare provider.1 For kidney transplantation, non-adherence to the immunosuppressive regimen is common and is increasingly recognized as an important predictor of poor long-term posttransplant outcomes.2,3 Non-adherence is defined as “any deviation from the prescribed medication regimen sufficient to influence adversely the regimen’s intended effect.”4
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Sabaté E. Adherence to Long-Term Therapies: Evidence for Action. World Health Organisation, Geneva, 2003.
Matas AJ, Humar A, Gillingham KJ et al. Five preventable causes of kidney graft loss in the 1990 s: a single-center analysis. Kidney Int 2002;62:704–714.
Nankivell BJ, Chapman JR. Chronic allograft nephropathy: current concepts and future directions. Transplantation 2006;81:643–654.
Fine RN, Becker Y, De Geest S. Nonadherence Consensus Summary Conference Report. Am J Transplant 2009;9:35–41.
Kiley DJ, Lam CS, Pollak R. A study of treatment compliance following kidney transplantation. Transplantation 1993;55(1):51–56.
De Geest S, Borgermans L, Gemoets H et al. Incidence, determinants, and consequences of subclinical noncompliance with immunosuppressive therapy in renal transplant recipients. Transplantation 1995;59(3):340–347.
Nevins TE, Kruse L, Skeans MA et al. The natural history of azathioprine compliance after renal transplantation. Kidney Int 2001;60(4):1565–1570.
Butler JA, Peveler RC, Roderick P et al. Measuring compliance with drug regimens after renal transplantation: comparison of self-report and clinician rating with electronic monitoring. Transplantation 2004;77(5):786–789.
Weng FL, Israni AK, Joffe MM et al. Race and electronically measured adherence to immunosuppressive medications after deceased donor renal transplantation. J Am Soc Nephrol 2005;16(6):1839–1848.
Denhaerynck K, Steiger J, Bock A et al. Prevalence and risk factors of non-adherence with immunosuppressive medication in kidney transplant patients. Am J Transplant 2007;7:108–116.
Takemoto SK, Pinsky BW, Schnitzler MA et al. A retrospective analysis of immunosuppression compliance, dose reduction and discontinuation in kidney transplant recipients. Am J Transplant 2007;7:2704–2711.
Schäfer-Keller P, Steiger J, Bock A et al. Diagnostic accuracy of measurement methods to assess non-adherence to immunosuppressive drugs in kidney transplant recipients. Am J Transplant 2008;8(3):616–626.
Dew MA, DiMartini AF, De Vito Dabbs A et al. Rate and risk factors for nonadherence to the medical regimen after adult solid organ transplantation. Transplantation 2007;83(7):858–873.
Dobbels F, Van Damme-Lombaerts R, Vanhaecke J, De Geest S. Growing pains: nonadherence with the immunosuppressive regimen in adolescent transplant recipients. Pediatr Transplant 2005;9(3):381–390.
Siegal BR, Greenstein SM. Postrenal transplant compliance from the perspective of African-Americans, Hispanic-Americans, and Anglo-Americans. Adv Ren Replace Ther 1997;4(1):46–54.
Chisholm MA, Lance CE, Williamson GM et al. Development and validation of the immunosuppressant therapy adherence instrument (ITAS). Patient Educ Couns 2005;59(1):13–20.
17. Denhaerynck K, Schäfer-Keller P, Young J et al. Examining the assumptions regarding valid electronic monitoring of medication therapy: development of a validation framework and its application on a European sample of kidney transplant patients. BMC Med Res Methodol 2008;8:E-pub ahead of printing.
Schellmer DA, Zelikovsky N. The challenges of using medication event monitoring technology with pediatric transplant patients. Pediatr Transplant 2007;11:422–428.
Osterberg L, Blaschke T. Adherence to medication. N Eng J Med 2005;353(5):487–497.
Gaston RS, Hudson SL, Ward M et al. Late renal allograft loss: noncompliance masquerading as chronic rejection. Transplant Proc 1999;31(4A):21S–23S.
Vlaminck H, Maes B, Evers G et al. Prospective study on late consequences of subclinical non-compliance with immunosuppressive therapy in renal transplant patients. Am J Transplant 2004;4(9):1509–1513.
Irish W, Sherrill B, Brennan DC et al. Three-year posttransplant graft survival in renal-transplant patients with graft function at 6 months receiving tacrolimus or cyclosporine microemulsion within a triple-drug regimen. Transplantation 2003;76(12):1686–1690.
Hricik DE, Augustine JJ, Knauss TC et al. Long-term graft outcomes after steroid withdrawal in African American kidney transplant recipients receiving sirolimus and tacrolimus. Transplantation 2007;83:277–281.
Reinke P, Fietze E, Docke WD et al. Late acute rejection in long-term renal allograft recipients. Diagnostic and predictive value of circulating activated T cells. Transplantation 1994;58(1):35–41.
Delucchi A, Gutierrez H, Arrellano P et al. Factors that influence nonadherence in immunosuppressant treatment in pediatric transplant recipients: a proposal for an educational strategy. Transplant Proc 2008;40:3241–3243.
Jarzembowski T, John E, Panaro F et al. Impact of non-compliance on outcome after pediatric kidney transplantation: an analysis in racial subgroups. Pediatr Transplant 2004;8(4):367–371.
Cecka JM, Gjertson DW, Terasaki PI. Pediatric renal transplantation; a review of the UNOS data. Pediatr Transplant 1997;1:55–64.
Brodehl J, Bokenkamp A, Hoyer PF et al. Long-term results of cyclosporin A therapy in children. J Am Soc Nephrol 1992;2(12 Suppl):S246–S254.
Gerson AC, Furth SL, Neu AM, Fivush BA. Assessing associations between medication adherence and potentially modifiable psychosocial variables in pediatric kidney transplant recipients and their families. Pediatr Transplant 2004;8(6):543–550.
Rosenberger J, van Dijk JP, Nagyova I et al. Predictors of perceived health status in patients after kidney transplantation. Transplantation 2006;81(9):1306–1310.
Goetzmann L, Sarac N, Ambühl P et al. Psychological response and quality of life after transplantation: a comparison between heart, lung, liver and kidney recipients. Swiss Med Wkly 2008;33–34:477–483.
Remorino R, Taylor J. Smoothing things over: the transition from pediatric to adult care for kidney transplant recipients. Prog Transplant 2006;16(4):303–308.
Watson AR. Non-compliance and transfer from paediatric to adult transplant units. Pediatr Nephrol 2000;14(6):469–472.
Cleemput I, Kesteloot K, Vanrenterghem Y et al. The economic implications of non-adherence after renal transplantation. Pharmacoeconomics 2004;22(18):1217–1234.
Hansen R, Seifeldin R, Noe L. Medication adherence in chronic disease: issues in posttransplant immunosuppression. Transplant Proc 2007;39:1287–1300.
Schweizer RT, Rovelli M, Palmeri D et al. Noncompliance in organ transplant recipients. Transplantation 1990;49:374–377.
Bittar AE, Keitel E, Garcia CD et al. Patient noncompliance as a cause of late kidney graft failure. Transplant Proc 1992;24(6):2720–2721.
Chisholm MA, Kwong WJ, Spivey CA. Associations of characteristics of renal transplant recipients with clinicians’ perceptions of adherence to immunosuppressant therapy. Transplantation 2007;84:1145–1150.
Meyers KE, Weiland H, Thomson PD. Paediatric renal transplantation non-compliance. Pediatr Nephrol 1995;9(2):189–192.
Tucker CM, Petersen S, Herman KC et al. Self-regulation predictors of medication adherence among ethnically different pediatric patients with renal transplants. J Pediatr Psychol 2001;26(8):455–464.
Frazier PA, Davis-Ali SH, Dahl KE. Correlates of noncompliance among renal transplant recipients. Clin Transplant 1994;8(6):550–557.
Ghods AJ, Nasrollahzadeh D, Argani H. Risk factors for noncompliance to immunosuppressive medications in renal transplant recipients. Transplant Proc 2003;35(7):2609–2611.
Chisholm MA, Lance CE, Williamson GM et al. Development and validation of an immunosuppressant therapy adherence barrier instrument. Nephrol Dial Transplant 2005;20(1):181–188.
Rodriguez A, Diaz M, Colon A et al. Psychosocial profile of noncompliant transplant patients. Transplant Proc 1991;23:1807–1809.
Rapisarda F, Tarantino A, De Vecchi A et al. Dialysis and kidney transplantation: similarities and differences in the psychological aspects of noncompliance. Transplant Proc 2006;38(4):1006–1009.
Foulkes LM, Boggs SR, Fennell RS et al. Social support, family variables, and compliance in renal transplant children. Pediatr Nephrol 1993;7(2):185–188.
Feinstein S, Keich R, Becker-Cohen R et al. Is noncompliance among adolescent renal transplant recipients inevitable? Pediatrics 2005;115(4):969–973.
48. Simons LE, McCormick ML, Mee LL et al. Parent and patient perspective on barriers to medication adherence in adolescent transplant recipients. Pediatr Transplant 2008;E-pub ahead of printing.
Achille MA, Ouellette A, Fournier S et al. Impact of stress, distress and feelings of indebtedness on adherence to immunosuppressants following kidney transplantation. Clin Transplant 2006;20(3):301–306.
Maikranz JM, Steele RG, Dreyer ML et al. The relationship of hope and illness-related uncertainty to emotional adjustment and adherence among pediatric renal and liver transplant recipients. J Pediatr Psychol 2007;32(5):571–581.
Bullington P, Pawola L, Walker R et al. Identification of medication non-adherence factors in adolescent transplant patients: the patient’s viewpoint. Pediatr Transplant 2007;11:914–921.
Blowey DL, Hebert D, Arbus GS et al. Compliance with cyclosporine in adolescent renal transplant recipients. Pediatr Nephrol 1997;11(5):547–551.
Butler JA, Peveler RC, Roderick P et al. Modifiable risk factors for non-adherence to immunosuppressants in renal transplant recipients: a cross-sectional study. Nephrol Dial Transplant 2004;19(12):3144–3149.
Fennell RS, Tucker C, Pedersen T. Demographic and medical predictors of medication compliance among ethnically different pediatric renal transplant patients. Pediatr Transplant 2001;5(5):343–348.
Rosenberger J, Geckova AM, van Dijk JP et al. Prevalence and characteristics of noncompliant behaviour and its risk factors in kidney transplant recipients. Transplant Int 2005;18(9):1072–1078.
Sketris I, Waite N, Grobler K et al. Factors affecting compliance with cyclosporine in adult renal transplant patients. Transplant Proc 1994;26(5):2538–2541.
Ichimaru N, Kakuta T, Abe M et al. Treatment adherence in renal transplant recipients: A questionnaire survey on immunosuppressants. Transplant Proc 2008;40:1362–1365.
Liu WJ, Zaki M. Medication compliance among renal transplant patients: a Hospital Kuala Lumpur experience. Med J Malaysia 2004;59(5):649–658.
Douglas S, Blixen C, Bartucci MR. Relationship between pretransplant noncompliance and posttransplant outcomes in renal transplant recipients. J Transpl Coord 1996;6:53–58.
Gremigni P, Bacchi F, Turrini C et al. Psychological factors associated with medication adherence following renal transplantation. Clin Transplant 2007;21:710–715.
Penkower L, Dew MA, Ellis D et al. Psychological distress and adherence to the medical regimen among adolescent renal transplant recipients. Am J Transplant 2003;3(11):1418–1425.
Gordon EJ, Prohaska TR, Gallant MP et al. Adherence to immunosuppression: a prospective diary study. Transplant Proc 2007;39:3081–3085.
Chisholm MA, Vollenweider LJ, Mulloy LL et al. Renal transplant patient compliance with free immunosuppressive medications. Transplantation 2000;70:1240–1244.
Chisholm MA, Mulloy LL, Jagadeesan M et al. Impact of clinical pharmacy services on renal transplant patients’ compliance with immunosuppressive medications. Clin Transplant 2001;15(5):330–336.
De Geest S, Schafer-Keller P, Denhaerynck K et al. Supporting medication adherence in renal transplantation (SMART): a pilot RCT to improve adherence to immunosuppressive regimens. Clin Transplant 2006;20(3):359–368.
Hardstaff R, Green K, Talbot D. Measurement of compliance posttransplantation – the results of a 12-month study using electronic monitoring. Transplant Proc 2003;35(2):796–797.
Fennell RS, Foulkes LM, Boggs SR. Family-based program to promote medication compliance in renal transplant children. Transplant Proc 1994;26(1):102–103.
Henning Beier U. Financial incentives to promote prolonged renal graft survival: potential for patients and public health. Med Hypotheses 2008;70:218–220.
69. Chaudhuri A, Salvatierra O Jr, Sarwal MM. Extended daclizumab monotherapy for rejection-free survival in non-adherent adolescent recipients of renal allografts. Pediatr Transplant 2008;E-pub ahead of printing.
Abecassis MM, Seifeldin R, Riordan ME. Patient outcomes and economics of once-daily tacrolimus in renal transplant patients: results of a modeling analysis. Transplant Proc 2008;40:1443–1445.
Dhanireddy KK, Maniscalco J, Kirk AD. Is tolerance induction the answer to adolescent non-adherence? Pediatr Transplant 2005;9:357–363.
72. Haynes RB, Ackloo E, Sahota N et al. Interventions for enhancing medication adherence. Cochrane Database Syst Rev 2008;16(2):CD 000011.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer-Verlag US
About this chapter
Cite this chapter
Dobbels, F., Fine, R.N. (2010). Adherence to the Immunosuppressive Regimen in Adult and Pediatric Kidney Transplant Recipients. In: McKay, D., Steinberg, S. (eds) Kidney Transplantation: A Guide to the Care of Kidney Transplant Recipients. Springer, Boston, MA. https://doi.org/10.1007/978-1-4419-1690-7_22
Download citation
DOI: https://doi.org/10.1007/978-1-4419-1690-7_22
Published:
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4419-1689-1
Online ISBN: 978-1-4419-1690-7
eBook Packages: MedicineMedicine (R0)